THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY
Patent Owner
Stats
- 117 US PATENTS IN FORCE
- 35 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 117 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 3,760 Total Citation Count
- Mar 28, 1984 Earliest Filing
- 99 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0297,931 SULFIDATED NANOSCALE ZEROVALENT IRON AND METHOD OF USE THEREOFApr 13, 16Oct 19, 17[B82Y, B22F, C02F]
2017/0273,922 UREA AND BIS-UREA BASED COMPOUNDS AND ANALOGUES THEREOF USEFUL IN THE TREATMENT OF ANDROGEN RECEPTOR MEDIATED DISEASES OR DISORDERSOct 02, 15Sep 28, 17[A61K, C07D, C07C]
2017/0226,598 A BACILLUS METHYLOTROPHICUS STRAIN AND METHOD OF USING THE STRAIN TO INCREASE DROUGHT RESISTANCE IN A PLANTJul 24, 15Aug 10, 17[C12R, A01N, C12N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9920084 Ionic tags for synthesis of oligoribonucleotidesAug 23, 12Mar 20, 18[C07H, C07F, C07D, C40B]
9856208 Method for producing an arene with an aromatic C—N bond ortho to an aromatic C—O bondSep 02, 16Jan 02, 18[C07F, C07D, C07C]
9849153 Compositions and methods for preventing and treating diseases and environmentally induced health disordersAug 12, 16Dec 26, 17[A61K, A23L]
9822890 Method and system for pre-programmed self-power microfluidic circuitsAug 30, 12Nov 21, 17[F16K, B01L, F15C]
9783428 Production of high strength hydrochloric acid from calcium chloride feed streams by crystallizationApr 06, 16Oct 10, 17[C22B, C01B, E04B, C01F]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0000,846 USE OF A NEUROFILAMENT PEPTIDE FOR THE TREATMENT OF GLIOMAAbandonedAug 05, 16Jan 05, 17[A61K]
2016/0326,585 INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOFAbandonedFeb 22, 16Nov 10, 16[C12Q, C07K]
2016/0045,882 NANOFLUID WITH NANOPARTICLE-DECORATED MULTIWALL CARBON NANOTUBES AND METHOD OF PREPARATION THEREOFAbandonedMar 17, 14Feb 18, 16[C09K, B01J]
2016/0018,489 METHODS AND SYSTEMS RELATING TO HIGH RESOLUTION MAGNETIC RESONANCE IMAGINGAbandonedMay 28, 15Jan 21, 16[G01R]
2016/0002,310 MODIFIED INGAP PEPTIDES FOR TREATING DIABETESAbandonedFeb 14, 14Jan 07, 16[A61K, C07K]
2015/0322,445 SELF-INCOMPATIBILITY SYSTEM FOR MAKING BRASSICACEAE HYBRIDAbandonedMay 06, 15Nov 12, 15[C12N, A01H, C07K]
2015/0307,532 THIENOPYRIMIDINE INHIBITORS OF FARNESYL AND/OR GERANYLGERANYL PYROPHOSPHATE SYNTHASEAbandonedNov 19, 13Oct 29, 15[C07F, C07D]
2015/0231,254 POLYNUCLEOTIDE-POLY(DIOL) CONJUGATES, PROCESS OF PREPARATION AND USES THEREOFAbandonedFeb 17, 15Aug 20, 15[A61K, C12N]
2015/0177,732 METHOD OF MANUFACTURING OPTICAL FIBERS, TAPERED OPTICAL FIBERS AND DEVICES THEREOFAbandonedJan 20, 15Jun 25, 15[G05B]
2015/0140,566 INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOFAbandonedMay 27, 13May 21, 15[C12Q]
2015/0033,738 METHOD OF EXTRACTING ENERGY FROM A CAVITY CREATED BY MINING OPERATIONSAbandonedFeb 22, 13Feb 05, 15[F24J]
2015/0017,636 Detection and Monitoring of Macrocyclic Lactone Resistance in NematodesAbandonedJul 10, 14Jan 15, 15[C12Q]
2014/0377,769 LAMIN A/C AND PRELAMINS AS INDICATORS OF FRAILTY AND VULNERABILITY OR RESILIENCY TO ADVERSE HEALTH OUTCOMESAbandonedDec 14, 12Dec 25, 14[G01N]
2014/0378,541 Synthetic Epigallocatechin Gallate (EGCG) AnalogsAbandonedJun 15, 12Dec 25, 14[A61K, C12N, C07C]
2014/0219,279 METHODS AND SYSTEMS FOR NETWORK ADDRESS LOOKUP ENGINESAbandonedFeb 07, 14Aug 07, 14[H04L]
2014/0155,487 METHOD FOR CORRECTING A LIPID IMBALANCE IN A SUBJECTAbandonedFeb 05, 14Jun 05, 14[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.